Dental Pain - Pipeline Review, H2 Pharmaceutical 2016
"Dental
Pain - Pipeline Review, H2 2016"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Markets Direct's latest Pharmaceutical and Healthcare disease
pipeline guide Dental Pain - Pipeline Review, H2 2016, provides an
overview of the Dental Pain (Central Nervous System) pipeline
landscape.
A
pain in the tooth is called dental pain. This can be caused by tooth
decay, damaged filling, tooth fracture, etc. Symptoms of a toothache
may include: tooth pain that may be sharp, throbbing, or constant. In
some people, pain results only when pressure is applied to the tooth.
Swelling around the tooth, fever or headache and foul-tasting
drainage from the infected tooth occurs. Treatment for a toothache
depends on the cause.
Report
Highlights
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Dental Pain - Pipeline Review, H2 2016, provides comprehensive
information on the therapeutics under development for Dental Pain
(Central Nervous System), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
The
Dental Pain (Central Nervous System) pipeline guide also reviews of
key players involved in therapeutic development for Dental Pain and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase III, Phase
II, Phase I, Preclinical and Discovery stages are 1, 2, 1, 1 and 1
respectively.Dental Pain.
Scope
-
The pipeline guide provides a snapshot of the global therapeutic
landscape of Dental Pain (Central Nervous System).
-
The pipeline guide reviews pipeline therapeutics for Dental Pain
(Central Nervous System) by companies and universities/research
institutes based on information derived from company and
industry-specific sources.
-
The pipeline guide covers pipeline products based on several stages
of development ranging from pre-registration till discovery and
undisclosed stages.
-
The pipeline guide features descriptive drug profiles for the
pipeline products which comprise, product description, descriptive
licensing and collaboration details, R&D brief, MoA & other
developmental activities.
-
The pipeline guide reviews key companies involved in Dental Pain
(Central Nervous System) therapeutics and enlists all their major and
minor projects.
-
The pipeline guide evaluates Dental Pain (Central Nervous System)
therapeutics based on mechanism of action (MoA), drug target, route
of administration (RoA) and molecule type.
Reasons
to buy
-
Procure strategically important competitor information, analysis, and
insights to formulate effective R&D strategies.
-
Recognize emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive
advantage.
-
Find and recognize significant and varied types of therapeutics under
development for Dental Pain (Central Nervous System).
-
Classify potential new clients or partners in the target demographic.
-
Develop tactical initiatives by understanding the focus areas of
leading companies.
-
Plan mergers and acquisitions meritoriously by identifying key
players and its most promising pipeline therapeutics.
-
Formulate corrective measures for pipeline projects by understanding
Dental Pain (Central Nervous System) pipeline depth and focus of
Indication therapeutics.
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
Comments
Post a Comment